Alpha Cognition Announces Officer Change: A New Chapter for the Company
Welcome to the Alpha Cognition Blog! A Farewell to Don Kalkofen VANCOUVER, British Columbia–(BUSINESS WIRE)–Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (“Alpha Cognition” or the “Company”), a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, announces that Don Kalkofen has resigned as the Chief Financial Officer of the Company to pursue other…